We show that while in vivo GITR ligation does not globally abrogate Treg suppressive activity, it does impair Treg tumor infiltration and leads to loss of foxp3 expression within intra-tumor Tregs, suggesting a localized abrogation of suppression. The gene discussed is TNFRSF18; the disease is neoplasm.